Kurt A. Gustafson
2017 - Spectrum Pharmaceuticals
In 2017, Kurt A. Gustafson earned a total compensation of $1.9M as Executive Vice President and Chief Financial Officer at Spectrum Pharmaceuticals, a 80% increase compared to previous year.
Compensation breakdown
| Bonus | $237,500 |
|---|---|
| Option Awards | $343,300 |
| Salary | $500,000 |
| Stock Awards | $661,213 |
| Other | $124,965 |
| Total | $1,866,978 |
Gustafson received $661.2K in stock awards, accounting for 35% of the total pay in 2017.
Gustafson also received $237.5K in bonus, $343.3K in option awards, $500K in salary and $125K in other compensation.
Rankings
In 2017, Kurt A. Gustafson's compensation ranked 5,839th out of 14,666 executives tracked by ExecPay. In other words, Gustafson earned more than 60.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,839 out of 14,666 | 60th |
Division Manufacturing | 2,125 out of 5,770 | 63rd |
Major group Chemicals And Allied Products | 662 out of 2,074 | 68th |
Industry group Drugs | 511 out of 1,730 | 71st |
Industry Pharmaceutical Preparations | 405 out of 1,329 | 70th |
Source: SEC filing on May 7, 2018.
Gustafson's colleagues
We found three more compensation records of executives who worked with Kurt A. Gustafson at Spectrum Pharmaceuticals in 2017.
News
OmniAb CEO Matthew Foehr's 2022 pay jumps 26% to $6.7M
May 1, 2023
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2021 pay jumps 110% to $7.8M
April 27, 2022
Spectrum Pharmaceuticals CEO Joseph Turgeon's 2019 pay jumps 21% to $5.7M
April 22, 2020
Spectrum Pharmaceuticals COO Thomas Riga's 2018 pay jumps 388% to $5.3M
April 23, 2019